Hennig Arzneimittel GmbH & Co.KG

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 1
Shared contracts: 1 (multi-supplier framework agreements)
Period: 1 October 2026 – 1 October 2026

Its main clients

DAK-Gesundheit · 1 contract

Where and what

Supplies · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
1 February 2028 re-tender around August 2027	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betahistin, ATC N07CA01 für die Zeit 01.02.26 - 31.01.28 (zzgl. Verlängerungsoption 1x12 Monate) DAK-Gesundheit	ratiopharm GmbH Viatris Healthcare GmbH Hennig Arzneimittel GmbH & Co.KG BG ALIUD / STADAPHARM GbR 5 bids received	€1

Contracts won

Date	Contract	Buyer	Amount
01/10/2026	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betahistin, ATC N07CA01 für die Zeit 01.02.26 - 31.01.28 (zzgl. Verlängerungsoption 1x12 Monate)	DAK-Gesundheit	€1 shared by 4

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.